GRI Bio Inc. (GRI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.06M
Last updated: Nov 17, 2026 at 4:15 PM ET
GRI Bio Inc. (GRI) Stock Chart
GRI Bio (GRI) has a latest price of $1.34 on Nov 17, 2026. Its price fell 97.2% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.2%.
Price Chart
From Feb 2021 to Oct 2026, its highest month-end close was $9,620,465.67 in Feb 2022 and its lowest $1.38 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GRI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GRI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 22.5%, and over 6 months it fell 39.9%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 96.9%.
| Period | Change |
|---|---|
| 1 month | -7.6% |
| 3 months | -22.5% |
| 6 months | -39.9% |
| 12 months | -97.2% |
| 12 months, with dividends | -97.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -100.0% | -96.9% |
| 5 years | -100.0% | -95.2% |
Price by Year
Its best calendar year was 2022, when the price fell 95.2%, and its weakest was 2025, when it fell 98.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.53 | -77.9% |
| 2025 | $6.91 | -98.2% |
| 2024 | $394.63 | -97.6% |
| 2023 | $16,690.01 | -95.6% |
| 2022 | $377,528.42 | -95.2% |
Trading Range
The price is 22.2% below its 50-day average of $1.72 and 33.9% below its 200-day average of $2.03.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.34 | |
| 50-day average | $1.72 | -22.2% |
| 200-day average | $2.03 | -33.9% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.63 |
| Largest fall, 1 year | -97.8% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GRI
What is GRI's 1-year price change?
GRI Bio's price fell 97.2% over the past 12 months. With dividends included, the 12-month total return was -97.2%.
What is GRI's 5-year price change?
GRI Bio's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.2%. These figures leave out dividends.
What is GRI's beta?
GRI Bio's 1-year beta against the S&P 500 is 0.63, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 97.8%.
Is the GRI chart free?
Yes. Advanced Charting for GRI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GRI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors